We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00868855
Recruitment Status : Terminated (poor enrollment)
First Posted : March 25, 2009
Last Update Posted : December 13, 2017
Information provided by (Responsible Party):
Vanderbilt University Medical Center ( Vanderbilt University )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2010
  Study Completion Date : December 2010